Advantage Alpha Capital Partners LP Trims Holdings in HealthEquity, Inc. $HQY

Key Points

• Advantage Alpha Capital Partners LP reduced its stake in HealthEquity, Inc. by 14%, selling 10,097 shares and holding a total of 61,916 shares now valued at approximately $5.47 million.
• HealthEquity's stock price opened at $91.06, with a market capitalization of $7.87 billion and a P/E ratio of 66.47.
• HealthEquity reported a quarterly earnings of $0.97 per share, exceeding analysts' estimates, and set its FY 2026 guidance at $3.610-3.78 EPS.

Advantage Alpha Capital Partners LP trimmed its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 14.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,916 shares of the company's stock after selling 10,097 shares during the quarter. HealthEquity accounts for 1.3% of Advantage Alpha Capital Partners LP's holdings, making the stock its 18th largest holding. Advantage Alpha Capital Partners LP owned about 0.07% of HealthEquity worth $5,472,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Hancock Whitney Corp lifted its stake in HealthEquity by 1.0% in the fourth quarter. Hancock Whitney Corp now owns 13,326 shares of the company's stock worth $1,279,000 after acquiring an additional 133 shares during the period. Xponance Inc. raised its holdings in shares of HealthEquity by 1.1% in the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock valued at $1,097,000 after purchasing an additional 136 shares in the last quarter. Fifth Third Bancorp raised its holdings in shares of HealthEquity by 17.5% in the 1st quarter. Fifth Third Bancorp now owns 955 shares of the company's stock valued at $84,000 after purchasing an additional 142 shares in the last quarter. Greenleaf Trust lifted its position in shares of HealthEquity by 7.8% in the 1st quarter. Greenleaf Trust now owns 2,407 shares of the company's stock worth $213,000 after purchasing an additional 175 shares during the period. Finally, State of Alaska Department of Revenue boosted its stake in shares of HealthEquity by 1.8% during the first quarter. State of Alaska Department of Revenue now owns 10,136 shares of the company's stock valued at $895,000 after purchasing an additional 180 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In related news, EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president directly owned 75,689 shares in the company, valued at $8,519,553.84. This trade represents a 43.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president owned 53,225 shares in the company, valued at $5,414,579.25. The trade was a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 291,744 shares of company stock valued at $32,705,007 in the last three months. 1.50% of the stock is owned by insiders.

HealthEquity Stock Down 2.7%

Shares of HQY traded down $2.40 during midday trading on Monday, hitting $87.42. 905,205 shares of the company's stock traded hands, compared to its average volume of 1,008,071. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $7.56 billion, a price-to-earnings ratio of 63.81, a price-to-earnings-growth ratio of 1.39 and a beta of 0.54. HealthEquity, Inc. has a 1 year low of $73.84 and a 1 year high of $116.65. The firm's fifty day moving average is $96.78 and its 200-day moving average is $96.43.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.During the same period in the prior year, the company posted $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. As a group, sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently commented on HQY shares. The Goldman Sachs Group boosted their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. Royal Bank Of Canada lifted their price target on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Raymond James Financial restated a "strong-buy" rating and set a $120.00 price objective (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Finally, JMP Securities lifted their target price on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research note on Wednesday, June 4th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, HealthEquity presently has an average rating of "Buy" and a consensus target price of $118.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.